In the last few years, there has been some pushback against the potential over-use (and detriment) of mammograms and prostate specific antigen tests.

CNN: Jolie's choice carries risks along with benefits

Last month the task force advised against routine prostate-specific antigen (PSA) tests to screen for prostate cancer.

ECONOMIST: The philosophical error that plagues American health care

Elsewhere, Celera Diagnostics, Abbott Labs and closely held Genomic Health also are pursuing prognostic gene tests for prostate cancer (and other tumors).

FORBES: Men, Cancer & Hope